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We study a susceptible-vaccinated–infected–recovered (SVIR) epidemic-spreading model with diversity of
infection rate of the individuals. By means of analytical arguments as well as extensive computer simulations,
we demonstrate that the heterogeneity in infection rate can either impede or accelerate the epidemic spreading,
which depends on the amount of vaccinated individuals introduced in the population as well as the contact
pattern among the individuals. Remarkably, as long as the individuals with different capability of acquiring the
disease interact with unequal frequency, there always exist a cross point for the fraction of vaccinated, below
which the diversity of infection rate hinders the epidemic spreading and above which expedites it. The overall
results are robust to the SVIR dynamics defined on different population models; the possible applications of the
results are discussed.
PACS numbers: 05.65.+b, 87.23.Ge, 02.50.Le, 89.75.Fb
I. INTRODUCTION
Infectious diseases have always been the great enemy of
human health. Historically, large outbreaks of epidemic usu-
ally posed a great threat to health and caused great loss for
individuals. In some sense, the history of humans is a history
of struggle with all kinds of diseases, from the Black Death in
medieval Europe to the recently notorious severe acute res-
piratory syndrome [1–3], avian influenza [4, 5], swine in-
fluenza [6, 7], etc.
So far, vaccination is the most effective approach to pre-
venting transmission of vaccine-preventable diseases, such as
seasonal influenza and influenza like epidemics, as well as re-
ducing morbidity and mortality [8]. In a voluntary vaccination
program, the individuals are subject not only to social factors
such as religious belief and human rights, but also to various
other conditions such as risk of infection, prevalence of dis-
ease, coverage, and cost of vaccination.
Recently, a great deal of effort has been devoted to the in-
vestigation of the interplay between vaccine coverage, disease
prevalence, and the vaccinating behavior of individuals by in-
tegrating game theory into traditional epidemiological mod-
els [8–19]. For brief reviews of this research topic, we re-
fer the reader to Refs. [20, 21] and reference therein. Bauch
et al. used game theory to explain the relationship between
group interest and self-interest in smallpox vaccination pol-
icy [8, 9] and found that voluntary vaccination was unlikely
to reach the group-optimal level. Vardavas and co-workers
investigated the effect of voluntary vaccination on the preva-
lence of influenza based on minority game theory and showed
that severe epidemics could not be prevented unless vacci-
nation programs offer incentives [10]. Zhang et al. studied
the epidemic spreading with voluntary vaccination strategy on
both Erdo¨s-Re´nyi random graphs and Baraba´si-Albert scale-
free networks [12]. They found that disease outbreak can be
more effectively inhibited on scale-free networks rather than
∗ wuzhx@lzu.edu.cn
† guanjy@lzu.edu.cn
on random networks, which is attributed to the fact that the
hub nodes of scale-free networks are more inclined to getting
vaccinated after balancing the pros and cons. More recently,
Fu and co-workers proposed a game-theoretic model to study
the dynamics of vaccination behavior on lattice and complex
networks [13, 15]. They found that the population structure
causes both advantages and problems for public health: It can
promote voluntary vaccination to high levels required for herd
immunity when the cost for vaccination is sufficiently small,
whereas small increases in the cost beyond a certain thresh-
old will cause vaccination to plummet, and infection to rise,
more dramatically than in well-mixed populations. Another
research line studying the effect of human behavior on the dy-
namics of epidemic spreading considers mainly the coevolu-
tion of node dynamics and network structure (the so-called
adaptive networks [22]), which can affect considerably the
spreading of a disease [23–25].
In most classical epidemiological models [26, 27], the in-
dividuals in the population are assumed to be identical, e.g.,
all susceptible individuals acquire the disease with the same
probability whenever in contact with an infected individual,
and all infected individuals recover, or go back to being sus-
ceptible, with the same rate. Such consideration is, however,
far from the actual situation. Generally, catching a disease
could be caused by many complex factors and there might be
great difference among the individuals in the contact rate [28],
the infection rate (or disease transmission rate) [29, 30], the
recovery rate, the cost when the individual is infected, and
so forth. One example of such a scenario would be the case
where the population is divided into a relatively wealthy class
(e.g., representing urban residents), which is less susceptible
to infectious disease being considered due to better living con-
ditions and/or health care, and a class of relatively impover-
ished (e.g., representing rural residents), which is more sus-
ceptible to infection. An alternative view is to regard roughly
the whole population as composed of two main groups, say,
youths and adults, where the former is more resistant to dis-
ease than the latter, owning to their stronger physique and im-
mune system.
In the present work, we relax the assumption of identical
nature of the individuals and take into account their hetero-
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2geneity in acquiring disease when in contact with infectious
individuals. To do this, we divide the whole population into
two groups, youths (hereafter group A) and adults (group B)
for simplicity, with the same size, and assume that the individ-
uals from group B are more likely to be infected than those
from group A. For the sake of comparison, we presume that
only the disease transmission rate for the individuals in the
two groups are distinct and other parameters, including the
recovery rate, the cost of infection, and the cost for vaccina-
tion, are identical. By doing so we hope to catch any possible
effects on disease prevalence and vaccination coverage caused
by the variability of susceptibility. Our results presented be-
low show that the heterogeneity in infection rate has a sig-
nificant influence on disease spreading and hence cannot be
ignored in the forecast of epidemic size and vaccination cov-
erage.
Our paper is organized as follows. In Sec. II we define our
model and give detailed information for the numerical simu-
lation method and the parametrizations. In Sec. III we present
and analyze the main results of our model. We summarize and
discuss the results in Sec. IV.
II. MODEL DEFINITION
It is well known that the contact pattern among individu-
als dramatically impacts the spatiotemporal dynamics of epi-
demic spreading in a population [26, 27]. In order to examine
the robustness of the results of our model, we consider two
types of population models, namely, a simple metapopulation
model and a spatially structured population model, as illus-
trated in Fig. 1.
In the metapopulation model, the whole population is di-
vided into two subpopulations with equal size, namely, group
A and group B. Within each subpopulation, the individuals
are assumed to be homogeneously mixed, that is, every indi-
vidual has the same opportunity to be in contact with every-
one else. Generally speaking, because of the diversity in so-
cial conditions or lifestyles, the individuals living in an urban
area would be more likely to interact with those also living the
same area and less likely to interact with those in the suburb.
Therefore, we consider the distinct contact pattern among the
individuals to study its impact. This is done by assuming that
any pair of individuals from different (the same) groups have
an interaction frequency  (1-). Here  is restricted to the
interval [0,0.5]. In the spatially structured population model,
we consider two kinds of occupation of the individuals on a
square lattice to introduce the diversity of interaction pattern
among them. To be more specific, in the first case, the youths
and the adults are arranged in a random way such that they can
interact with the same frequency, which is similar to the case
of  = 0.5 in the metapopulation case. In the second case, the
individuals are regularly prearranged to gather together with
the same type of individuals [see Fig. 1(c)]. In this way, we
are able to investigate how the mixing pattern affects the epi-
demic spreading in the population.
We implement our susceptible-vaccinated–infected–
recovered epidemic-spreading dynamics in the following
way. The epidemic strain infects an initial number of indi-
viduals I0 and then spreads in the population according to
the classical susceptible-infected-recovered(SIR) epidemio-
logical model, with per-day transmission rate r for each pair
of susceptible-infected contact and recovery rate g for each
infected individual getting immune to the disease. Whenever
the vaccinated compartment is involved in the epidemiologi-
cal model, a fraction fV of individuals are randomly chosen
in the whole population in the initial stage to get vaccinated.
For simplicity, here we assume that vaccination grants perfect
immunity for the infectious disease. The epidemic continues
until there are no more newly infected individuals. As such,
those unvaccinated susceptible individuals would either be
infected or successfully escape from infection at the end of
each spreading season.
In realistic situations, to vaccinate or not to vaccinate is
sometimes the business of the individuals. Thus, except for
the above case where the fraction of vaccinated individuals is
compulsively introduced, we also consider a voluntary vacci-
nation program for preventing an influenzalike infectious dis-
ease, in which individuals need to decide whether or not to
receive a vaccine each season based on their perceived risk of
disease infection. Following previous studies [10, 11, 13, 15],
we model the vaccination dynamics as a two-stage game. At
the first stage, each individual decides whether or not to get
vaccinated, which will incur a cost CV , including the imme-
diate monetary cost for vaccine and the potential risk of vac-
cine side effects. Individuals catching the epidemic will suf-
fer from an infection cost CI , which may account for disease
complications, expenses for treatment, etc. Those individu-
als who escape infection are free riders and pay for nothing.
Without loss of generality, we set CI = 1 and let c = CV /CI
describe the relative cost of vaccination, whose value is re-
stricted in the region of [0,1] (otherwise, doing nothing would
be better than getting vaccinated). The second stage is the
same epidemic spreading processes as described before. After
each spreading season, the individuals are allowed to rechoose
their choice for vaccination based on a pairwise comparison
rule (more details will be given below).
We carry out stochastic simulations for the above epidemi-
ological (game-theoretic) processes in both population mod-
els, wherein each seasonal epidemiological process is imple-
mented by using the well-known Gillespie algorithm [31, 32].
In particular, at any time t, we calculate each individual’s
transition rate λi(t). The rate for any susceptible individual
becoming infected is λi(t) = r × kinf and kinf is the num-
ber of infected neighbors of the focal individual. The rate
for any infected individual recovering is λi(t) = g. The re-
covered individuals do not change state and the rate for them
is therefore λi(t) = 0. Summing up all of them, we yield
the total transition rate ω(t) = Σiλi(t). With this value in
hand, the time at which the next transition event occurs is
t′ = t + ∆t, where ∆t is sampled from an exponential dis-
tribution with mean 1ω(t) (if we generate a uniform random
number u ∈ [0, 1), then the time interval is ∆t = − ln(1−u)ω(t) ).
The individual whose state is chosen to change at time t′ is
sampled with a probability proportional to λi(t). That is,
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FIG. 1. (Color online) Schematic illustration of population models we studied in the main text. (a) Simple metapopulation model composed of
two subpopulations, within each one consisting of the same type of individuals. (b) Individuals from different groups are randomly arranged
on a square lattice. (c) Individuals from different groups are regularly arranged on the lattice. TheA-type andB-type individuals are indicated
by blue (dark gray) and green (light gray) squares, respectively.
a uniform random number v ∈ [0, 1) is generated and if
Σk−1j=1λj(t)/ω(t) < v < Σ
k
j=1λj(t)/ω(t), then individual k
is chosen to change state. This elementary step is repeated
until there are no infected individuals left in the population.
III. ANALYSIS AND RESULTS
A. Metapopulation without vaccinated compartment
We first examine our model in metapopulations. For conve-
nience, the two groups A and B are denoted by the subscripts
a and b, respectively. According to the above illustrated sce-
nario, the time evolution of population states for group A can
be expressed as the following deterministic ordinary differen-
tial equations:
dSa
dt = −raNSa[(1− )Ia + Ib], (1)
dIa
dt = raNSa[(1− )Ia + Ib]− gIa, (2)
dRa
dt = gIa. (3)
As mentioned before, the parameter  is the cross contact co-
efficient, which stands for the contact frequency between in-
dividuals from different groups.
For the whole system that includes groups A and B, we
have the following equations:
dS
dt = −raNSa [(1− ) Ia + Ib]− rbNSb [(1− ) Ib + Ia] ,
(4)
dI
dt = raNSa [(1− ) Ia + Ib]
+ rbNSb [(1− ) Ib + Ia]− gI, (5)
dR
dt = g(Ia + Ib) = gI. (6)
In the limit  → 0, the basic reproduction number (whose
value identifies the expected number of secondary infections
produced by an infected individual during that individual’s in-
fectious period within the entire susceptible population) of
groups A and B can be approximately written as R0a =
raN/g and R0b = rbN/g, respectively. By taking the av-
erage over each group, we obtain the effective basic reproduc-
tion number of the infectious diseaseR0 = (ra + rb)N/2g =
〈r〉N/g [33] where 〈r〉 is the average value of the disease
transmission rate of the whole population.
By varying the value of ra and rb, we are able to introduce
the difference in transmission rate of the infectious disease
for the individuals. For the sake of comparison, we keep the
average value of the transmission rate fixed as 〈r〉 = (ra +
rb)/2. Denoting ra/rb by x, the relative disease transmission
rate for the two types of individuals, after some simple algebra
we have
ra =
2x〈r〉
1 + x
, and rb =
2〈r〉
1 + x
. (7)
When x is close to zero, there exists a great difference between
the individuals in group A and those in group B in acquiring
the disease (i.e., we consider the case where the youths are
very resistant to the infection, while the adults are very vul-
nerable to the disease). As x goes to unity, the variation of the
disease transmission rate among the two groups vanishes.
Let us show in Fig. 2 the influence of the cross contact coef-
ficient  on the epidemic spreading in the population without
a vaccinated compartment. In the case of the limit x→ 1, we
have ra ≈ rb, which means that the possibilities of acquir-
ing the disease through susceptible-infected contact for the
individuals from the two groups are almost the same. As a
consequence, the final epidemic size fR, i.e., the average frac-
tion of recovered individuals in the whole population, does not
change much as the parameter  varies. Note that with the cur-
rent parametrization settings the final epidemic size without
vaccination is about 89.3% for x = 1.0 [13]. As x diminishes,
fR decreases considerably. This point can be understood by
considering the case of → 0. In such a case, as demonstrated
in Appendix V, due to the concavity of fR as a function ofR0,
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FIG. 2. (Color online) Epidemic spreading in the metapopulation
model without the vaccinated compartment. The final epidemic size
fR is plotted as a function of the cross coefficient  for several differ-
ent values of the relative disease transmission rate x. The lines are for
the analytical predictions from Eqs. (4)–(6). The symbols are simu-
lations obtained by carrying out the Gillespie algorithm. The param-
eters are the total population sizeN = NA+NB = 10 000, average
value of the disease transmission rate 〈r〉 = 2.5
3N
day−1 person−1,
recovery rate g = 1
3
day−1, and number of initial infection seeds
Ia=Ib=10. Simulation results are averaged over 100 independent
runs.
the decrease of epidemic size fRa in group A cannot be offset
by the increase of fRb in group B and consequently the final
epidemic size of the whole system will decrease continuously
as x decreases. In particular, when the value of x is less than
0.25, the value ofR0a will be smaller than unity, which means
that the epidemic cannot spread throughout group A. Hence
fR of the whole population is mainly contributed by fRb and
converges approximately to a value ≈ 0.5 for x < 0.25.
With the increment of , the more frequent contact between
the two groups will infect more individuals in group A, while
the somewhat less frequent contact among those individuals
from group B has just a slight impact on the final fRb (see
Appendix V). The introduction of heterogeneity of the infec-
tion rate can greatly suppress the prevalence of the infectious
disease.
B. Metapopulation with vaccinated compartment
We now incorporate the vaccinated compartment into the
epidemic spreading in the metapopulation model. We de-
note by fV a the proportion of the population initially vacci-
nated in group A. In our work we assume the same fraction
of initially vaccinated individuals for the two groups, that is,
fV a = fV b = fV . For given values of fV , x, and , we ob-
tain the final epidemic size by implementing stochastic simu-
lations as described in Sec. II. The simulation results are sum-
marized in Fig. 3, which are in good agreement with those
predicted by numerically solving Eqs. (4)–(6).
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FIG. 3. (Color online) Epidemic spreading in the metapopulation
model with the vaccinated compartment. The final epidemic size
fR is plotted as a function of the fraction of vaccinated individuals
fV for several different values of the relative disease transmission
rate x. The lines are for analytical predictions from deterministic
equations and the symbols are obtained by simulations. The cross
contact coefficient (a)  = 0.5 and (b)  = 0.1. Other parameters
are the same as in Fig. 2. Simulation results are averaged over 100
independent runs.
The overall result is that with the involvement of the vac-
cinated compartment, the final epidemic size will gradually
decrease with the increase of fV , which is expected since vac-
cination can provide perfect immunity to the infectious dis-
ease and a sufficiently large fraction of vaccinated individuals
can completely prohibit the propagation of the infectious dis-
ease. Though the difference between fR for x = 1.0 and that
for x < 1.0 is vanishing in the limit of large fV , there exists
a qualitative difference for the variation. When the individu-
als from the two groups interact quite frequently  = 0.5, the
smaller the relative disease transmission rate x is, the smaller
the final epidemic size fR is. Such a dynamic scenario, how-
ever, changes when the interaction frequency among the in-
5dividuals from distinct groups is decreased. Specifically, a
crossover behavior of fR as a function of fV emerges as the
parameter  drops close to zero. We notice that there arises a
critical value of fV , say, fV c (whose value is about 0.45), be-
low which the presence of heterogeneity in infection rate for
the individuals from different groups can hinder the epidemic
spreading, while above which the opposite effect takes place
(see Appendix VI for more details). It is worth pointing out
that for sufficiently small , the individuals in the two groups
almost interact with others within the same group, which leads
to the clustering of susceptible individuals with a high infec-
tion rate of the disease (in group B). Consequently, the dis-
ease prevalence is enlarged as compared to the case of a homo-
geneous interaction pattern of the two groups [e.g., the curve
for x = 0.02 in the case of  = 0.1 is always above that in the
case of  = 0.5 (not shown here)].
C. Spatially structured population with vaccinated
compartment
Now we study our model in a spatially structured popu-
lation, where the individuals are located on a square lattice.
For the sake of comparison, we calibrated the epidemic pa-
rameters to ensure that the infection risk in an unvaccinated
population (without variation of infection) is equal across all
population structures, that is, fR for x = 1 in the case of
spatially structured population should be the same as fR for
x = 1 in the case of a metapopulation. The simulation re-
sults are displayed in Fig. 4, from which we note that the final
epidemic size fR decreases much more rapidly as compared
to that in the metapopulation case when the vaccination level
increases. When the two types of individuals are randomly
prearranged, fR decreases monotonically as the variation of
infection increases for each vaccination level. Noticeably, we
find that the crossover behavior of fR as a function of fV still
exists when the interaction frequency between the two types
of individuals reduces to a very low level. From Fig. 4(b) we
can see clearly that there is a crossing point near fV c = 0.1.
For fV < fV c, the heterogeneity in infection can efficiently
hinder the disease spreading, while it promotes the propaga-
tion for fV > fV c, similar to the results in Fig. 3(b) obtained
for the metapopulation model.
D. Spatially structured population with vaccination dynamics
In what follows we investigate how the vaccination dynam-
ics (i.e., we allow the individuals to change their vaccination
behavior based on previous experience [13]) affects the epi-
demic spreading in structured populations. In the initial state,
we randomly choose half of the population to get vaccinated.
At the end of each epidemic spreading season, we give the
individuals a chance to update their strategies for vaccination
before the new one starts. We implement a pairwise compar-
ison process for the strategy updating. Specifically, whenever
an individual i updates one’s vaccination strategy, one just
chooses an individual j randomly from one’s nearest neigh-
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FIG. 4. (Color online) Epidemic spreading in spatially structured
populations with the vaccinated compartment. The final epidemic
size fR is plotted as a function of the vaccination level fV for several
different values of the relative disease transmission rate x. The differ-
ent types of individuals are (a) randomly arranged as in Fig. 1(b) and
(b) regularly arranged as in Fig. 1(c). The parameters are the total
population size N=100×100, average value of the disease transmis-
sion rate 〈r〉 = 0.46 day−1 person−1, recovery rate g = 1
3
day−1,
and number of initial infection seeds Ia=Ib=10. Simulation results
are averaged over 100 independent runs.
bors to compare their cost (or payoff) and then adopts the
vaccination choice of j with a probability dependent on the
payoff difference [34–36]
qij =
1
1 + exp[−β(Pj − Pi)] , (8)
where Pi and Pj correspond to the payoffs of the two involved
individuals and β denotes the strength of the selection. Un-
less otherwise specified, we select β = 1.0, implying that
better-performing individuals are readily imitated, but it is not
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FIG. 5. (Color online) Epidemic spreading and vaccination dynamics in spatially structured populations. (a)–(c) The final epidemic size fR
and (d)–(f) the final vaccination coverage fV are plotted as a function of the cost for vaccination c for three typical values of the relative disease
transmission rate x. Open and closed symbols correspond to the results yielded for randomly and regularly arranged populations, respectively.
Other parameters are the same as in Fig. 4. Simulation results are averaged over 100 independent runs. The lines are a guide to the eyes.
impossible to adopt the behavior of an individual performing
worse. What we are interested in this case is how many indi-
viduals are infected and the vaccination coverage in the final
stable state. The results shown in Fig. 5 are the average of the
last 1000 iterations among the total 5000 in 100 independent
simulations.
We plot in Fig. 5 the epidemic size fR and the vaccina-
tion level fV in the steady state as a function of the relative
cost for vaccination c for two differently arranged populations
on square lattice. From Figs. 5(a)–5(c) we observe that as
the value of x goes down, i.e., the heterogeneity in infection
rate for the two types of individuals becomes more notable,
the final epidemic level in the randomly arranged population
(the open symbols) changes much more evidently than that
in the case of regularly arranged population (the closed sym-
bols). In particular, for x = 0.5, the final fR in the randomly
arranged population is always greater than that in the regu-
larly arranged population as c increases, albeit the vaccina-
tion level in the former case is slightly larger than that in the
latter case for c <∼ 0.25 [see Fig. 5(d)]. For x = 0.3, in
the randomly arranged population, though the growth trend
of fR is more apparently for small c, it attains at a smaller
level for large enough values of c (when the vaccination level
evolves to zero), which is comparable to the case of a regu-
larly arranged population. As x decreases even to 0.1, fR in a
randomly arranged population can just grow to a much lower
level as compared to that in the case of a regularly arranged
population, despite the fact that the vaccination level is zero
for most c values [see Fig. 5(f)]. The reason is that the A-type
individuals are difficult to infect even though they did not re-
ceive a vaccine when x is too small and as such they play the
role of a natural obstructer to prevent large-scale spreading
of the disease in the population. In addition, those unvacci-
nated A-type individuals will attract other individuals to not
get vaccinated, giving rising to very low level of vaccination
in the steady state [Figs. 5(e) and 5(f)]. For a regularly ar-
ranged population, however, since the B-type individuals are
clustered together, they are very prone to the attack of disease,
and consequently the final epidemic can reach a rather large
level.
IV. CONCLUSION AND DISCUSSION
In summary, we have incorporated the heterogeneity in in-
fection rate of individuals and also the vaccination dynamics
into the traditional susceptible-infected-recovered compart-
mental epidemic model to study their potential effects on the
disease prevalence and vaccination coverage. For this pur-
7pose, we have considered a more practical framework where
the whole population is classed into two types of groups
whose members are endowed with different capabilities in
catching a disease. To keep things simple, the individuals
within the same group are assumed to be identical in their
infection rate. The proposed model has been investigated in
a simple metapopulation and spatially structured populations,
with and without involvement of vaccination, by using numer-
ical simulations as well as analytical treatments.
We have shown that whether the introduction of hetero-
geneity in the infection rate of the individuals exerts positive
or negative effects (i.e., hampers or expedites) on the epidemic
spreading depends closely on both the extent of the hetero-
geneity of the disease transmission rate and the interaction
frequency among the individuals from different groups. To be
more specific, the heterogeneity in infection rate can always
give rise to a decrease of the final epidemic size provided the
individuals from different groups interact with equal likeli-
hood. Nonetheless, as the individuals become more inclined
to interact mainly with others from the same group, the het-
erogeneity in infection rate can hinder the epidemic spreading
only in the situation that the fraction of individuals vaccinated
is low enough. Very surprising, this just facilitates the epi-
demic spreading in a regime with the presence of a large frac-
tion of vaccinated individuals (but not large enough to eradi-
cate the disease completely).
Our work is expected to provide some valuable instructions
for the prediction and intervention of epidemic spreading in
the real world. The results summarized in Figs. 2–5 sug-
gest that when evaluating the seriousness of an epidemic, we
should take into account both the factors of the diversity of the
infection rate of the individuals and the interaction patterns
among them simultaneously; otherwise we may overestimate
or underestimate the spreading trend. Alternatively, without
such considerations, we may overshoot or undershoot the de-
sired amount of action when developing, regulating, and mak-
ing vaccine policy. In addition, when individuals are allowed
to change their vaccination decisions according to their expe-
rience and observations, we find that as the heterogeneity in
infection rate for the two types of individuals becomes more
noticeable, the final epidemic level in randomly arranged pop-
ulation changes much more evidently than that in the case of a
regularly arranged population, hence giving us a vital clue as
to how to make efficient vaccine campaign, namely, we should
distribute the vaccine in the population as widely as possible
so that the spreading path of the disease can be efficiently sup-
pressed.
To summarize, our proposed model captures essential ele-
ments in real-world epidemic spreading, which has not been
fully discussed previously. Therefore, we believe our results
will give some insights to the policy makers. There are still
many issues, such as diversity of recovery rate, heterogeneous
cost for infection and vaccination, and more complex contact-
network structures, which are totally overlooked in the present
work and deserve to be explored in the future. In addition, the
spread of awareness of the epidemic and/or the vaccination
sentiment would also impact greatly the vaccination behavior
of the individuals and hence the epidemic outbreaks [37–39].
We hope our work could stimulate further work in this line of
research.
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V. APPENDIX A
Here we present theoretical analysis for the simple
metapopulation model. For convenience, let us denote
〈r〉N/g by C, which is kept as a constant. The combination
of Eqs. (1)–(3) with Eq. (7) yields
dSa
dRa
= − 2x1+xSaC
[
(1− ) +  IbIa
]
, (9)
dSa
dRb
= − 2x1+xSaC
[
(1− ) IaIb + 
]
, (10)
dSb
dRb
= − 21+xSbC
[
(1− ) +  IaIb
]
, (11)
dSb
dRa
= − 21+xSaC
[
(1− ) IbIa + 
]
. (12)
After eliminating IaIb and
Ib
Ia
from these equations we readily
obtain

Sa
dSa − x(1−)Sb dSb =
2Cx(1−2)
1+x dRb, (13)
1−
Sa
dSa − xSb dSb =
2Cx(1−2)
1+x dRa. (14)
Now we integrate these two equations with respect to time
from 0 to∞. By using the initial condition Sa(0) = Sb(0) ≈
1 and Ra(0) = Rb(0) = 0 and the final state Ia(∞) =
Ib(∞) = 0, we get the following two transcendental equa-
tions for the final epidemic size Ra(∞) and Rb(∞) for each
group:
ln [1−Ra(∞)] = 2Cx1+x [(1− )Ra(∞) + Rb(∞)] , (15)
ln [1−Rb(∞)] = 2C1+x [(1− )Rb(∞) + Ra(∞)] .(16)
What we want to figure out is the relationship between the
final epidemic size fR and the cross coefficient , so we take
a derivative of Eqs. (15) and (16) with respect to  and get
1
Ra(∞)−1
dRa(∞)
d
= − 2Cx1+x
[
−Ra(∞) + (1− )dRa(∞)d +Rb(∞) + dRb(∞)d
]
,(17)
1
Rb(∞)−1
dRb(∞)
d
= − 2Cx1+x
[
−Rb(∞) + (1− )dRb(∞)d +Ra(∞) + dRa(∞)d
]
.(18)
After doing some algebra we obtain(
1
1−Ra(∞) − 2Cx1+x
)
dRa(∞)
d
= −
(
x
1−Rb(∞) − 2Cx1+x
)
dRb(∞)
d . (19)
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FIG. 6. (Color online) Solutions of the equation R(∞) = 1 −
exp−R0R(∞), where the final epidemic size fR = R(∞) as a func-
tion of basic reproduction ratio R0 is shown.
We can rewrite this equation as
dRa(∞)
d
= −KdRb(∞)
d
, (20)
where
K =
x
1−Rb(∞) − 2Cx1+x
1
1−Ra(∞) − 2Cx1+x
. (21)
In the case of  = 0, it is easy to verify numerically that
K > 1 for all our x values of interest (say, x > 0.01). More
intuitively, for SIR model in a well-mixed population, the fi-
nal epidemic size is determined by the self-consistent equa-
tion R(∞) = 1 − exp−R0R(∞). Figure 6 features the solu-
tions, from which we note that fR is a concave function of
R0. If we decrease the value of x such that in the limit of
 = 0 the variables R0a and R0b always satisfy the relation-
shipsR0a < R0b and (R0a +R0b) /2 = C = R0, then due to
the concave curvature, the variation of the final epidemic size
in group A will be more remarkable than that in group B, as
illustrated in Fig. 6. For each fixed value of x, as  increases,
the increasingly frequent contact among the individuals from
different groups will have a greater affect on Ra(∞) than on
Rb(∞) (as long as x is not too small), giving rise to the in-
crease of fR in the whole population. Since Ra(∞) increases
and Rb(∞) decreases with the increment of , the value of K
will decrease monotonically according to Eq. (21), which is
reflected correctly in Fig. 2.
VI. APPENDIX B
Here we demonstrate the existence of the crossover behav-
ior for the curves of fR as a function of fV = y for dif-
ferent values of x. In a well-mixed population, we know
the final fraction of recovered population for the SIR model
satisfying the equation R(∞) = 1 − exp−R0R(∞). When
TABLE I. Comparisons of the intersecting points (fV c, fR) of the
curves for x = 1.0 and 0.02 predicted by Eqs. (27), (22), and (24)
with those obtained from direct stochastic simulations, with different
values of .
 = 0.05  = 0.1  = 0.2  = 0.3
0.470, 0.237(6)a 0.477, 0.228(5) 0.482, 0.210(2) 0.507, 0.175(5)
0.473, 0.235(7)b 0.478, 0.227(7) 0.491, 0.206(4) 0.512, 0.171(5)
a Results of (fV c, fR) obtained from stochastic simulations.
b Results of (fV c, fR) predicted by analytical treatments.
a proportion y of preemptive vaccination in introduced be-
fore the epidemic starts, we can readily obtain R(∞) =
(1−y) (1− exp−R0R(∞)) . For our proposed model, we con-
sider two limited cases. The first case is x = 1, i.e., the indi-
viduals in the two groups are identical, and in such a case we
have
Rb(∞) |x=1= (1− y)
(
1− exp−R0bRb(∞)|x=1) , (22)
R(∞) |x=1= Ra(∞) |x=1= Rb(∞) |x=1, (23)
where R0b = rbN/g = 〈r〉N/g = C.
The other limited case is x → 0, which means that the dis-
ease transmission rate for the individuals in group A is nearly
zero. By approximating Ra(∞) |x→0= 0 and combining
Eqs. (15) with (16) we have
Rb(∞) |x→0= (1− y)(1− exp−R0b(1−)Rb(∞)|x→0),(24)
R(∞) |x→0= Ra(∞)|x→0+Rb(∞)|x→02
= Rb(∞)|x→02 , (25)
where R0b = rbN/g = 2〈r〉N/g = 2C. We assume that the
curves of fR for the two cases have a crossing point so that
Rb(∞) |x=1= Rb(∞) |x→0
2
. (26)
Denoting Rb(∞) |x=1 by z, combining Eqs. (22), (24), and
(26), and recalling that C = 2.5, we obtain
exp−10(1−)z = 2 exp−2.5z −1. (27)
To validate the assumption, Eq. (27) must have an exact solu-
tion, which means that(
exp−10(1−)z
)′ |z=0< (2 exp−2.5z −1)′ |z=0 . (28)
Solving the inequality yields  < 0.5. That is to say, the
crossover behavior will always exist as long as  is strictly
smaller than one-half. From Eqs. (27) and (22) we have
d
dz
=
1
10
[
− 2.5 exp
−2.5z
z(2 exp−2.5z −1) −
ln(2 exp−2.5z −1)
z2
]
< 0,
(29)
dy
dz
=
exp−2.5z +2.5z exp−2.5z −1
(exp−2.5z −1)2 < 0. (30)
9By dividing Eq. (30) by (29) we get d/dy > 0, which indi-
cates that the crossing point will move to the right (i.e., the
curves intersect at larger values of y = fV ) with an increase
of the cross contact coefficient . In Table I we summarize
the crossing point values (fV c, fR) of the curves for x = 1.0
and 0.02 yielded by the stochastic simulations as well as those
predicted by Eqs. (27), (22), and (24). We notice that the re-
sults obtained from different methods match quite well with
each other. The invisible differences may be due to the finite-
system-size effect. Specifically, with increasing  the curves
for x = 1.0 and 0.02 intersect at points with larger fV c.
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